- call +1-201-465-4211
- email sales@mrinsights.biz
Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.
Scope of the Report:
This report focuses on the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market.
Chapter 1, to describe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, with sales, revenue, and price of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Pediatric Hepatitis B (CHO) Vaccine
1.2.2 Adult Hepatitis B (CHO) Vaccine
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck & Co., Inc.
2.1.1 Business Overview
2.1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline Plc
2.2.1 Business Overview
2.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer Inc.
2.3.1 Business Overview
2.3.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Pasteur
2.4.1 Business Overview
2.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 CSL Limited
2.5.1 Business Overview
2.5.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Emergent Biosolutions
2.6.1 Business Overview
2.6.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Serum Institute of India
2.7.1 Business Overview
2.7.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Analysis by Regions
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
5 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
5.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
6 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
6.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
6.4 France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
7.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
7.5 India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
8 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
8.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Countries
9.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Growth Rate (2013-2018)
10 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment by Type
10.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Pediatric Hepatitis B (CHO) Vaccine Sales Growth and Price
10.2.1 Global Pediatric Hepatitis B (CHO) Vaccine Sales Growth (2013-2018)
10.2.2 Global Pediatric Hepatitis B (CHO) Vaccine Price (2013-2018)
10.3 Adult Hepatitis B (CHO) Vaccine Sales Growth and Price
10.3.1 Global Adult Hepatitis B (CHO) Vaccine Sales Growth (2013-2018)
10.3.2 Global Adult Hepatitis B (CHO) Vaccine Price (2013-2018)
11 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment by Application
11.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast (2018-2023)
12.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast (2018-2023)
12.2.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast (2018-2023)
12.2.4 South America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast (2018-2023)
12.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Type (2018-2023)
12.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Picture
Table Product Specifications of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
Figure Glob
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
